Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts

Abstract Background Previous studies indicate that soyasaponins may reduce inflammation via modulating toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) signaling. However, its underlying mechanisms are still not fully understood. Methods Lipopolysaccharide (LPS)-challenged infla...

Full description

Bibliographic Details
Main Authors: Junbin Chen, Hidayat Ullah, Zhongdaixi Zheng, Xiangfu Gu, Chuhong Su, Lingyu Xiao, Xinglong Wu, Fei Xiong, Qing Li, Longying Zha
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12906-020-2864-2
_version_ 1819064278679814144
author Junbin Chen
Hidayat Ullah
Zhongdaixi Zheng
Xiangfu Gu
Chuhong Su
Lingyu Xiao
Xinglong Wu
Fei Xiong
Qing Li
Longying Zha
author_facet Junbin Chen
Hidayat Ullah
Zhongdaixi Zheng
Xiangfu Gu
Chuhong Su
Lingyu Xiao
Xinglong Wu
Fei Xiong
Qing Li
Longying Zha
author_sort Junbin Chen
collection DOAJ
description Abstract Background Previous studies indicate that soyasaponins may reduce inflammation via modulating toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) signaling. However, its underlying mechanisms are still not fully understood. Methods Lipopolysaccharide (LPS)-challenged inflamed male ICR mice were intervened by intragastrical administration with 10 and 20 μmol/kg·BW of soyasaponin A1, A2 or I for 8 weeks. The serum inflammatory markers were determined by commercial kits and the expression of molecules in TLR4/MyD88 signaling pathway in liver by real-time PCR and western blotting. The recruitments of TLR4 and MyD88 into lipid rafts of live tissue lysates were detected by sucrose gradient ultracentrifugation and western blotting. LPS-stimulated RAW264.7 macrophages were treated with 10, 20 and 40 μmol/L of soyasaponin A1, A2 or I for 2 h. MyD88-overexpressed HEK293T cells were treated with 20 and 40 μmol/L of soyasaponins (A1, A2 or I) or 20 μmol/L of ST2825 (a MyD88 inhibitor) for 6 h. The expression of molecules in TLR4/MyD88 signaling pathway were determined by western blotting. Data were analyzed by using one way analysis of variance or t-test by SPSS 20.0 statistical software. Results Soyasaponins A1, A2 or I significantly reduced the levels of tumor necrosis factor alpha (TNFα), interleukin (IL)-6 and nitric oxide (NO) in serum (p < 0.05), and decreased the mRNA levels of TNFα, IL-6, IL-1β, cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) (p < 0.05), the protein levels of myeloid differentiation protein 2 (MD-2), TLR4, MyD88, toll-interleukin1 receptor domain containing adaptor protein (TIRAP), phosphorylated interleukin-1 receptor-associated kinase 4 (p-IRAK-4), phosphorylated interleukin-1 receptor-associated kinase 1 (p-IRAK-1) and TNF receptor associated factor 6 (TRAF6) (p < 0.05), and the recruitments of TLR4 and MyD88 into lipid rafts in liver (p < 0.05). In LPS-stimulated macrophages, soyasaponins A2 or I significantly decreased MyD88 (p < 0.05), soyasaponins A1, A2 or I reduced p-IRAK-4 and p-IRAK-1 (p < 0.05), and soyasaponin I decreased TRAF6 (p < 0.05). In MyD88-overexpressed HEK293T cells, soyasaponins (A1, A2 or I) and ST2825 significantly decreased MyD88 and TRAF6 (p < 0.05). Conclusion Soyasaponins can reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts. This study provides novel understanding about the anti-inflammatory mechanism of soyasaponins.
first_indexed 2024-12-21T15:28:02Z
format Article
id doaj.art-424167ca645e4149925f453fdd6ec31a
institution Directory Open Access Journal
issn 2662-7671
language English
last_indexed 2024-12-21T15:28:02Z
publishDate 2020-06-01
publisher BMC
record_format Article
series BMC Complementary Medicine and Therapies
spelling doaj.art-424167ca645e4149925f453fdd6ec31a2022-12-21T18:58:51ZengBMCBMC Complementary Medicine and Therapies2662-76712020-06-0120111610.1186/s12906-020-2864-2Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid raftsJunbin Chen0Hidayat Ullah1Zhongdaixi Zheng2Xiangfu Gu3Chuhong Su4Lingyu Xiao5Xinglong Wu6Fei Xiong7Qing Li8Longying Zha9Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityDepartment of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityDepartment of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityDepartment of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityDepartment of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityDepartment of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityDepartment of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityDepartment of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityDepartment of Dietetics, Nanfang Hospital, Southern Medical UniversityDepartment of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical UniversityAbstract Background Previous studies indicate that soyasaponins may reduce inflammation via modulating toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88) signaling. However, its underlying mechanisms are still not fully understood. Methods Lipopolysaccharide (LPS)-challenged inflamed male ICR mice were intervened by intragastrical administration with 10 and 20 μmol/kg·BW of soyasaponin A1, A2 or I for 8 weeks. The serum inflammatory markers were determined by commercial kits and the expression of molecules in TLR4/MyD88 signaling pathway in liver by real-time PCR and western blotting. The recruitments of TLR4 and MyD88 into lipid rafts of live tissue lysates were detected by sucrose gradient ultracentrifugation and western blotting. LPS-stimulated RAW264.7 macrophages were treated with 10, 20 and 40 μmol/L of soyasaponin A1, A2 or I for 2 h. MyD88-overexpressed HEK293T cells were treated with 20 and 40 μmol/L of soyasaponins (A1, A2 or I) or 20 μmol/L of ST2825 (a MyD88 inhibitor) for 6 h. The expression of molecules in TLR4/MyD88 signaling pathway were determined by western blotting. Data were analyzed by using one way analysis of variance or t-test by SPSS 20.0 statistical software. Results Soyasaponins A1, A2 or I significantly reduced the levels of tumor necrosis factor alpha (TNFα), interleukin (IL)-6 and nitric oxide (NO) in serum (p < 0.05), and decreased the mRNA levels of TNFα, IL-6, IL-1β, cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) (p < 0.05), the protein levels of myeloid differentiation protein 2 (MD-2), TLR4, MyD88, toll-interleukin1 receptor domain containing adaptor protein (TIRAP), phosphorylated interleukin-1 receptor-associated kinase 4 (p-IRAK-4), phosphorylated interleukin-1 receptor-associated kinase 1 (p-IRAK-1) and TNF receptor associated factor 6 (TRAF6) (p < 0.05), and the recruitments of TLR4 and MyD88 into lipid rafts in liver (p < 0.05). In LPS-stimulated macrophages, soyasaponins A2 or I significantly decreased MyD88 (p < 0.05), soyasaponins A1, A2 or I reduced p-IRAK-4 and p-IRAK-1 (p < 0.05), and soyasaponin I decreased TRAF6 (p < 0.05). In MyD88-overexpressed HEK293T cells, soyasaponins (A1, A2 or I) and ST2825 significantly decreased MyD88 and TRAF6 (p < 0.05). Conclusion Soyasaponins can reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts. This study provides novel understanding about the anti-inflammatory mechanism of soyasaponins.http://link.springer.com/article/10.1186/s12906-020-2864-2SoyasaponinToll-like receptor 4 (TLR4)Myeloid differentiation factor 88 (MyD88)InflammationLipid raft
spellingShingle Junbin Chen
Hidayat Ullah
Zhongdaixi Zheng
Xiangfu Gu
Chuhong Su
Lingyu Xiao
Xinglong Wu
Fei Xiong
Qing Li
Longying Zha
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
BMC Complementary Medicine and Therapies
Soyasaponin
Toll-like receptor 4 (TLR4)
Myeloid differentiation factor 88 (MyD88)
Inflammation
Lipid raft
title Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
title_full Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
title_fullStr Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
title_full_unstemmed Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
title_short Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
title_sort soyasaponins reduce inflammation by downregulating myd88 expression and suppressing the recruitments of tlr4 and myd88 into lipid rafts
topic Soyasaponin
Toll-like receptor 4 (TLR4)
Myeloid differentiation factor 88 (MyD88)
Inflammation
Lipid raft
url http://link.springer.com/article/10.1186/s12906-020-2864-2
work_keys_str_mv AT junbinchen soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT hidayatullah soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT zhongdaixizheng soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT xiangfugu soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT chuhongsu soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT lingyuxiao soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT xinglongwu soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT feixiong soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT qingli soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts
AT longyingzha soyasaponinsreduceinflammationbydownregulatingmyd88expressionandsuppressingtherecruitmentsoftlr4andmyd88intolipidrafts